On Friday, Esperion Therapeutics Inc (NASDAQ: ESPR) trading session started at the price of On Friday, that was -1.72% drop from the session before settling in for the closing price of $2.32. A 52-week range for ESPR has been $1.58 – $3.94.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 7.64% over the last five years. When this article was written, the company’s average yearly earnings per share was at 85.28%. With a float of $195.08 million, this company’s outstanding shares have now reached $195.44 million.
The firm has a total of 240 workers. Let’s measure their productivity. In terms of profitability, gross margin is 81.57%, operating margin of 5.57%, and the pretax margin is -29.37%.
Esperion Therapeutics Inc (ESPR) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Esperion Therapeutics Inc stocks. The insider ownership of Esperion Therapeutics Inc is 0.99%, while institutional ownership is 65.84%. The most recent insider transaction that took place on Dec 17 ’24, was worth 7,866. In this transaction Chief Financial Officer of this company sold 3,245 shares at a rate of $2.42, taking the stock ownership to the 240,691 shares. Before that another transaction happened on Dec 17 ’24, when Company’s Chief Commercial Officer sold 2,234 for $2.43, making the entire transaction worth $5,426. This insider now owns 160,121 shares in total.
Esperion Therapeutics Inc (ESPR) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 85.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.90% during the next five years compared to 23.09% growth over the previous five years of trading.
Esperion Therapeutics Inc (NASDAQ: ESPR) Trading Performance Indicators
You can see what Esperion Therapeutics Inc (ESPR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.66, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach 0.22 in one year’s time.
Technical Analysis of Esperion Therapeutics Inc (ESPR)
Analysing the last 5-days average volume posted by the [Esperion Therapeutics Inc, ESPR], we can find that recorded value of 3.63 million was lower than the volume posted last year of 6.32 million. As of the previous 9 days, the stock’s Stochastic %D was 52.98%. Additionally, its Average True Range was 0.27.
During the past 100 days, Esperion Therapeutics Inc’s (ESPR) raw stochastic average was set at 29.66%, which indicates a significant increase from 20.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 136.81% in the past 14 days, which was higher than the 89.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.42, while its 200-day Moving Average is $2.24. Now, the first resistance to watch is $2.35. This is followed by the second major resistance level at $2.41. The third major resistance level sits at $2.47. If the price goes on to break the first support level at $2.23, it is likely to go to the next support level at $2.17. Should the price break the second support level, the third support level stands at $2.11.
Esperion Therapeutics Inc (NASDAQ: ESPR) Key Stats
There are 197,035K outstanding shares of the company, which has a market capitalization of 441.49 million. As of now, sales total 116,330 K while income totals -209,250 K. Its latest quarter income was 51,630 K while its last quarter net income were -29,520 K.
